Patents by Inventor Rena Aviva Mizrahi

Rena Aviva Mizrahi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240132593
    Abstract: The present disclosure provides antibodies to V-domain Ig-containing Suppressor of T cell Activation (VISTA) and compositions comprising such antibodies. Also provided are methods of using antibodies that specifically binds to VISTA to treat diseases, e.g., to treat cancer.
    Type: Application
    Filed: February 18, 2022
    Publication date: April 25, 2024
    Inventors: Shawn P. Iadonato, Thierry Guillaudeux, Eric J. Tarcha, David Scott Johnson, Adam Shultz Adler, Rena Aviva Mizrahi, Yoong Wearn Lim, Michael Asensio
  • Publication number: 20230287112
    Abstract: Provided herein are compositions comprising recombinant polyclonal proteins (RPPs) derived from mammalian plasma cells and plasmablasts. Also provided are methods of using the RPPs.
    Type: Application
    Filed: April 4, 2023
    Publication date: September 14, 2023
    Inventors: David Scott Johnson, Sheila Keating, Adam Shultz Adler, Michael Asensio, Kacy Stadtmiller, Emily Benzie, Ariel Niedecken, Angelica V. Medina-Cucurella, Rena Aviva Mizrahi, Yoong Wearn Lim
  • Publication number: 20230265171
    Abstract: Provided herein are compositions comprising recombinant polyclonal protein (RPP) derived from mammalian plasma cells and plasmablasts. Specifically, RPPs specific to Zika virus are provided. Also provided are the methods of using the RPP for treatment of viral infection and the methods of making the RPPs.
    Type: Application
    Filed: April 27, 2023
    Publication date: August 24, 2023
    Inventors: David Scott JOHNSON, Sheila KEATING, Adam Shultz ADLER, Michael ASENSIO, Kacy STADTMILLER, Emily BENZIE, Ariel NIEDECKEN, Angelica V. Medina-Cucurella, Rena Aviva MIZRAHI, Yoong Wearn LIM
  • Publication number: 20230265192
    Abstract: Provided herein are antigen-binding proteins (ABPs) that selectively bind to CTLA-4 and its isoforms and homologs, and compositions comprising the ABPs. Also provided are methods of using the ABPs, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: July 2, 2021
    Publication date: August 24, 2023
    Applicant: GigaGen, Inc.
    Inventors: David Scott JOHNSON, Adam Shultz ADLER, Rena Aviva MIZRAHI, Yoong Wearn LIM, Michael ASENSIO, Erica Lyn STONE
  • Patent number: 11718660
    Abstract: Provided herein are compositions comprising recombinant polyclonal protein (RPP) derived from mammalian plasma cells and plasmablasts. Specifically, RPPs specific to Zika virus are provided. Also provided are the methods of using the RPP for treatment of viral infection and the methods of making the RPPs.
    Type: Grant
    Filed: September 8, 2021
    Date of Patent: August 8, 2023
    Assignee: GigaGen, Inc.
    Inventors: David Scott Johnson, Sheila Keating, Adam Shultz Adler, Michael Asensio, Kacy Stadtmiller, Emily Benzie, Ariel Niedecken, Angelica V. Medina-Cucurella, Rena Aviva Mizrahi, Yoong Wearn Lim
  • Patent number: 11685779
    Abstract: Provided herein are compositions comprising recombinant polyclonal proteins (RPPs) derived from mammalian plasma cells and plasmablasts. Also provided are methods of using the RPPs.
    Type: Grant
    Filed: July 27, 2021
    Date of Patent: June 27, 2023
    Assignee: GigaGen, Inc.
    Inventors: David Scott Johnson, Sheila Keating, Adam Shultz Adler, Michael Asensio, Kacy Stadtmiller, Emily Benzie, Ariel Niedecken, Angelica V. Medina-Cucurella, Rena Aviva Mizrahi, Yoong Wearn Lim
  • Publication number: 20230124998
    Abstract: Provided herein are methods that enable parallel evaluation of multiple functional nucleic acids in individual cells or subpopulations of cells, in the context of incubation with other types of single cells. The key insight is concurrent measurement of polynucleic acids derived from small populations of at least two different cell types, such that function in one cell type is linked to the clonal identity of another cell. These methods simultaneously process thousands, millions, or more single cells or small populations of cells. The method integrates molecular, algorithmic, and engineering approaches. This invention has broad and useful application in a number of biological and medical fields, including immunology and drug discovery.
    Type: Application
    Filed: July 25, 2022
    Publication date: April 20, 2023
    Inventors: David Scott Johnson, Adam Shultz Adler, Matthew James Spindler, Rena Aviva Mizrahi
  • Patent number: 11441240
    Abstract: Provided herein are methods that enable parallel evaluation of multiple functional nucleic acids in individual cells or subpopulations of cells, in the context of incubation with other types of single cells. The key insight is concurrent measurement of polynucleic acids derived from small populations of at least two different cell types, such that function in one cell type is linked to the clonal identity of another cell. These methods simultaneously process thousands, millions, or more single cells or small populations of cells. The method integrates molecular, algorithmic, and engineering approaches. This invention has broad and useful application in a number of biological and medical fields, including immunology and drug discovery.
    Type: Grant
    Filed: May 16, 2019
    Date of Patent: September 13, 2022
    Assignee: GigaGen, Inc.
    Inventors: David Scott Johnson, Adam Shultz Adler, Matthew James Spindler, Rena Aviva Mizrahi
  • Patent number: 11427933
    Abstract: Provided herein are methods that enable parallel evaluation of multiple functional nucleic acids in individual cells or subpopulations of cells, in the context of incubation with other types of single cells. The key insight is concurrent measurement of polynucleic acids derived from small populations of at least two different cell types, such that function in one cell type is linked to the clonal identity of another cell. These methods simultaneously process thousands, millions, or more single cells or small populations of cells. The method integrates molecular, algorithmic, and engineering approaches. This invention has broad and useful application in a number of biological and medical fields, including immunology and drug discovery.
    Type: Grant
    Filed: August 3, 2021
    Date of Patent: August 30, 2022
    Assignee: GigaGen, Inc.
    Inventors: David Scott Johnson, Adam Shultz Adler, Matthew James Spindler, Rena Aviva Mizrahi
  • Publication number: 20220243197
    Abstract: Provided herein are compositions comprising recombinant polyclonal proteins (RPPs) derived from mammalian plasma cells and plasmablasts. Also provided are methods of using the RPPs.
    Type: Application
    Filed: April 30, 2020
    Publication date: August 4, 2022
    Inventors: David Scott Johnson, Adam Shultz Adler, Rena Aviva Mizrahi, Yoong Wearn Lim, Michael Asensio, Sheila Keating, Renee Leong, Jackson Leong
  • Publication number: 20220064303
    Abstract: Provided herein are antigen-binding proteins (ABPs) that selectively bind to CTLA-4 and its isoforms and homologs, and compositions comprising the ABPs. Also provided are methods of using the ABPs, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: December 27, 2019
    Publication date: March 3, 2022
    Inventors: David Scott Johnson, Adam Shultz Adler, Rena Aviva Mizrahi, Yoong Wearn Lim, Michael Asensio, Erica Lyn Stone
  • Publication number: 20220064268
    Abstract: Provided herein are compositions comprising recombinant polyclonal protein (RPP) derived from mammalian plasma cells and plasmablasts. Specifically, RPPs specific to Zika virus are provided. Also provided are the methods of using the RPP for treatment of viral infection and the methods of making the RPPs.
    Type: Application
    Filed: September 8, 2021
    Publication date: March 3, 2022
    Inventors: David Scott Johnson, Sheila Keating, Adam Shultz Adler, Michael Asensio, Kacy Stadtmiller, Emily Benzie, Ariel Niedecken, Angelica V. Medina-Cucurella, Rena Aviva Mizrahi, Yoong Wearn Lim
  • Publication number: 20220064302
    Abstract: Provided herein are antigen-binding proteins (ABPs) that selectively bind to PD-1 and its isoforms and homologs, and compositions comprising the ABPs. Also provided are methods of using the ABPs, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: December 27, 2019
    Publication date: March 3, 2022
    Inventors: David Scott Johnson, Adam Shultz Adler, Rena Aviva Mizrahi, Yoong Wearn Lim, Michael Asensio
  • Publication number: 20220056137
    Abstract: Provided herein are antigen-binding proteins (ABPs) that selectively bind to PD-L1 and its isoforms and homologs, and compositions comprising the ABPs. Also provided are methods of using the ABPs, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: December 27, 2019
    Publication date: February 24, 2022
    Inventors: David Scott Johnson, Adam Shultz Adler, Rena Aviva Mizrahi, Yoong Wearn Lim, Michael Asensio
  • Publication number: 20220041715
    Abstract: Provided herein are compositions comprising recombinant polyclonal proteins (RPPs) derived from mammalian plasma cells and plasmablasts. Also provided are methods of using the RPPs.
    Type: Application
    Filed: July 27, 2021
    Publication date: February 10, 2022
    Inventors: David Scott Johnson, Sheila Keating, Adam Shultz Adler, Michael Asensio, Kacy Stadtmiller, Emily Benzie, Ariel Niedecken, Angelica V. Medina-Cucurella, Rena Aviva Mizrahi, Yoong Wearn Lim
  • Publication number: 20210371851
    Abstract: Provided herein are methods that enable parallel evaluation of multiple functional nucleic acids in individual cells or subpopulations of cells, in the context of incubation with other types of single cells. The key insight is concurrent measurement of polynucleic acids derived from small populations of at least two different cell types, such that function in one cell type is linked to the clonal identity of another cell. These methods simultaneously process thousands, millions, or more single cells or small populations of cells. The method integrates molecular, algorithmic, and engineering approaches. This invention has broad and useful application in a number of biological and medical fields, including immunology and drug discovery.
    Type: Application
    Filed: August 3, 2021
    Publication date: December 2, 2021
    Inventors: David Scott Johnson, Adam Shultz Adler, Matthew James Spindler, Rena Aviva Mizrahi
  • Patent number: 11111490
    Abstract: Provided herein are methods that enable parallel evaluation of multiple functional nucleic acids in individual cells or subpopulations of cells, in the context of incubation with other types of single cells. The key insight is concurrent measurement of polynucleic acids derived from small populations of at least two different cell types, such that function in one cell type is linked to the clonal identity of another cell. These methods simultaneously process thousands, millions, or more single cells or small populations of cells. The method integrates molecular, algorithmic, and engineering approaches. This invention has broad and useful application in a number of biological and medical fields, including immunology and drug discovery.
    Type: Grant
    Filed: June 17, 2019
    Date of Patent: September 7, 2021
    Assignee: GigaGen, Inc.
    Inventors: David Scott Johnson, Adam Shultz Adler, Matthew James Spindler, Rena Aviva Mizrahi
  • Publication number: 20190390190
    Abstract: Provided herein are methods that enable parallel evaluation of multiple functional nucleic acids in individual cells or subpopulations of cells, in the context of incubation with other types of single cells. The key insight is concurrent measurement of polynucleic acids derived from small populations of at least two different cell types, such that function in one cell type is linked to the clonal identity of another cell. These methods simultaneously process thousands, millions, or more single cells or small populations of cells. The method integrates molecular, algorithmic, and engineering approaches. This invention has broad and useful application in a number of biological and medical fields, including immunology and drug discovery.
    Type: Application
    Filed: May 16, 2019
    Publication date: December 26, 2019
    Inventors: David Scott Johnson, Adam Shultz Adler, Matthew James Spindler, Rena Aviva Mizrahi
  • Publication number: 20190316118
    Abstract: Provided herein are methods that enable parallel evaluation of multiple functional nucleic acids in individual cells or subpopulations of cells, in the context of incubation with other types of single cells. The key insight is concurrent measurement of polynucleic acids derived from small populations of at least two different cell types, such that function in one cell type is linked to the clonal identity of another cell. These methods simultaneously process thousands, millions, or more single cells or small populations of cells. The method integrates molecular, algorithmic, and engineering approaches. This invention has broad and useful application in a number of biological and medical fields, including immunology and drug discovery.
    Type: Application
    Filed: June 17, 2019
    Publication date: October 17, 2019
    Inventors: David Scott Johnson, Adam Shultz Adler, Matthew James Spindler, Rena Aviva Mizrahi
  • Patent number: 10329557
    Abstract: Provided herein are methods that enable parallel evaluation of multiple functional nucleic acids in individual cells or subpopulations of cells, in the context of incubation with other types of single cells. The key insight is concurrent measurement of polynucleic acids derived from small populations of at least two different cell types, such that function in one cell type is linked to the clonal identity of another cell. These methods simultaneously process thousands, millions, or more single cells or small populations of cells. The method integrates molecular, algorithmic, and engineering approaches. This invention has broad and useful application in a number of biological and medical fields, including immunology and drug discovery.
    Type: Grant
    Filed: March 13, 2018
    Date of Patent: June 25, 2019
    Assignee: GigaGen, Inc.
    Inventors: David Scott Johnson, Adam Shultz Adler, Matthew James Spindler, Rena Aviva Mizrahi